93 related articles for article (PubMed ID: 23696149)
1. Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts.
Berasain C; Avila MA
Hepatology; 2013 Sep; 58(3):853-5. PubMed ID: 23696149
[No Abstract] [Full Text] [Related]
2. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma: current concepts and insights.
Gores GJ
Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
[No Abstract] [Full Text] [Related]
4. Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation.
DeMorrow S
Dig Liver Dis; 2009 Feb; 41(2):164-5. PubMed ID: 19112054
[No Abstract] [Full Text] [Related]
5. Intrahepatic cholangiocarcinoma arising in autosomal dominant polycystic kidney disease.
Sasaki M; Katayanagi K; Watanabe K; Takasawa K; Nakanuma Y
Virchows Arch; 2002 Jul; 441(1):98-100. PubMed ID: 12192647
[No Abstract] [Full Text] [Related]
6. [Cholangiocellular carcinoma (intrahepatic bile duct carcinoma)].
Tarao K; Tamai S; Ohkawa S; Miyakawa K; Aoki H
Ryoikibetsu Shokogun Shirizu; 1995; (7):476-9. PubMed ID: 8749530
[No Abstract] [Full Text] [Related]
7. The activation of platelet aggregation by human cholangiocarcinoma cells is mediated through thrombin receptor.
Akarasereenont P; Chotewuttakorn S; Aiamsa-Ard T; Thaworn A
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S710-21. PubMed ID: 12002913
[TBL] [Abstract][Full Text] [Related]
8. [Intrahepatic bile duct adenocarcinoma].
Terada T; Nakanuma Y
Ryoikibetsu Shokogun Shirizu; 1995; (7):402-4. PubMed ID: 8749507
[No Abstract] [Full Text] [Related]
9. JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?
Smirnova OV; Ostroukhova TY; Bogorad RL
World J Gastroenterol; 2007 Dec; 13(48):6478-91. PubMed ID: 18161917
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus and intrahepatic cholangiocarcinoma.
Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
[TBL] [Abstract][Full Text] [Related]
11. The molecular pathogenesis of cholangiocarcinoma.
Berthiaume EP; Wands J
Semin Liver Dis; 2004 May; 24(2):127-37. PubMed ID: 15192786
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
[TBL] [Abstract][Full Text] [Related]
13. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
[TBL] [Abstract][Full Text] [Related]
14. The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma.
Taguchi K; Aishima S; Asayama Y; Kajiyama K; Kinukawa N; Shimada M; Sugimachi K; Tsuneyoshi M
Hepatology; 2001 May; 33(5):1118-23. PubMed ID: 11343239
[TBL] [Abstract][Full Text] [Related]
15. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
[TBL] [Abstract][Full Text] [Related]
16. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
Gentilini A; Pastore M; Marra F; Raggi C
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma.
Wu T
Biochim Biophys Acta; 2005 Jul; 1755(2):135-50. PubMed ID: 15921858
[TBL] [Abstract][Full Text] [Related]
18. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
[TBL] [Abstract][Full Text] [Related]
19. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
20. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.
Sirica AE; Nathanson MH; Gores GJ; Larusso NF
Hepatology; 2008 Dec; 48(6):2040-6. PubMed ID: 18855901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
